Video: Hodgkin Lymphoma

Featuring Sonali M. Smith, MD (The University of Chicago)

**UPDATE: Since the filming of this video, nivolumab (Opdivo) has been approved by the FDA for the treatment of patients with classical Hodgkin lymphoma that have relapsed or progressed after an autologous stem cell transplant and who have been treated with brentuximab vedotin (Adcetris) post-transplant.

To learn more about Hodgkin lymphoma (HL), click here.

Lymphoma Research Foundation